Immutep Expands Part B of TACTI-002 Study
Follows positive efficacy and safety review Sydney, AUSTRALIA, March 05, 2021 (GLOBE NEWSWIRE) — –…
Follows positive efficacy and safety review Sydney, AUSTRALIA, March 05, 2021 (GLOBE NEWSWIRE) — –…
TEMPLE CITY, Calif., March 05, 2021 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent…
LEXINGTON, Mass., March 05, 2021 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
Webinar taking place on Friday, March 26th @ 10 am EDT BOULDER, Colo., March 05,…
TORONTO, March 05, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the…
DURHAM, N.C., March 05, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc., a clinical-stage biotechnology platform company…
PRINCETON, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare…
NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — LifeMD, Inc. (NASDAQ: LFMD) (formerly Conversion Labs),…
Tauriga 03-05-2021 Full Spectrum CBD Infused Chocolate Bites This Full Spectrum CBD Infused Product Line…
Significant progress advancing IMR-687 as an oral, once-a-day potentially disease modifying treatment for sickle cell…